MEDNAX 2019 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2019
October 15 2019 - 6:45AM
Business Wire
MEDNAX, Inc. (NYSE: MD), will host an investor conference call
and webcast on Friday, November 1, 2019 at 9:00 a.m. ET, to discuss
results from operations for the quarter and the nine months ended
September 30, 2019. A detailed press release will be issued the
morning of November 1, 2019 before the securities markets open.
The investor conference call will be webcast and can be accessed
at MEDNAX’s website, www.mednax.com/investors.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of
the nation's leading providers of physician services. Physicians
and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company
was founded in 1979, and today, through its affiliated professional
corporations, MEDNAX provides services through a network of more
than 4,250 physicians in all 50 states and Puerto Rico. In addition
to its national physician network, MEDNAX provides services to
healthcare facilities and physicians in over 40 states through two
complementary businesses, consisting of a management services
company and a consulting services company. Additional information
is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking
statements may include, but are not limited to, statements relating
to our objectives, plans and strategies, and all statements, other
than statements of historical facts, that address activities,
events or developments that we intend, expect, project, believe or
anticipate will or may occur in the future. These statements are
often characterized by terminology such as “believe,” “hope,”
“may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,”
“estimate,” “project,” “positioned,” “strategy” and similar
expressions, and are based on assumptions and assessments made by
MEDNAX’s management in light of their experience and their
perception of historical trends, current conditions, expected
future developments and other factors they believe to be
appropriate. Any forward-looking statements in this press release
are made as of the date hereof, and MEDNAX undertakes no duty to
update or revise any such statements, whether as a result of new
information, future events or otherwise. Forward-looking statements
are not guarantees of future performance and are subject to risks
and uncertainties. Important factors that could cause actual
results, developments, and business decisions to differ materially
from forward-looking statements are described in MEDNAX’s most
recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well
MEDNAX’s current reports on Form 8-K, filed with the Securities and
Exchange Commission, and include the effects of economic conditions
on MEDNAX’s business; the effects of the Affordable Care Act and
potential changes thereto or a repeal thereof; MEDNAX’s
relationships with government-sponsored or funded healthcare
programs, including Medicare and Medicaid, and with managed care
organizations and commercial health insurance payors; MEDNAX’s
ability to consummate the proposed disposition of MedData; the
performance of MedData subsequent to its disposition; the timing
and contribution of future acquisitions; the effects of share
repurchases; and the effects of MEDNAX’s shared services and
operational initiatives.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191015005320/en/
Charles Lynch Vice President, Strategy and Investor Relations
954-384-0175, x 5692 charles_lynch@mednax.com
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Sep 2023 to Sep 2024